Medical Equipment

Smart Biopsy Devices Industry Anticipated to Expand at 7.4% CAGR During the Forecast Period

November 18, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Smart Biopsy Devices Market From 2025 To 2034?

The valuation of the smart biopsy devices market demonstrated robust expansion throughout the preceding years, projecting an escalation from its 2024 standing of $2.85 billion to reach $3.01 billion by 2025, reflecting a sustained compounded annual growth rate of 5.6%; this upward trajectory observed during the historical phase is primarily linked to a rise in cancer diagnoses, a growing preference for procedures involving minimal invasion, advancements in the technology surrounding medical apparatus, and enhancements in the precision of diagnostic techniques.

Anticipating robust expansion, the sphere of smart biopsy devices is projected to reach a valuation of $4.01 billion by 2029, driven by a compound annual growth rate of 7.4%, with this escalated growth being fueled by the increasing demand for tailored medical treatments, progress in various imaging technologies, the growing necessity for biopsies to analyze biomarkers, the emergence of novel competitors in the marketplace, and improvements in data linkage capabilities. Key developments shaping the future trajectory of this market encompass the adoption of biopsies guided by robotics, the integration of artificial intelligence for biopsy support, the innovation surrounding cordless biopsy instruments, the proliferation of compact and handheld devices, and the implementation of systems that offer immediate navigational assistance.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12271&type=smp

Which Factors And Drivers Are Influencing The Smart Biopsy Devices Market In 2025?

Anticipated escalation in cancer occurrences is set to boost the expansion of the smart biopsy devices sector in the foreseeable future. Cancer represents a wide-ranging collection of diseases arising in virtually any bodily tissue or organ when anomalous cells multiply without restraint, breaching conventional limits, and subsequently invading adjacent structures or metastasizing to distant sites. The increasing diagnosis rate of cancer has consequently elevated the demand for highly accurate and targeted tissue specimens, thereby stimulating the development and refinement of smart biopsy apparatus incorporating enhanced molecular, imaging, and targeting functionalities essential for improving diagnostic accuracy and informing therapeutic strategies. To illustrate this trend, projections from the World Health Organization, the intergovernmental body based in Switzerland, indicated in January 2024 that more than 35 million new cancer diagnoses are anticipated by 2050, signifying a substantial 77% jump compared to the approximately 20 million cases and 9.7 million fatalities documented in 2022, directly underpinning the market growth for smart biopsy technologies through the increasing prevalence of cancer diagnoses.

What Are The Primary Types Of Segments Analyzed In The Smart Biopsy Devices Market?

The smart biopsy devicesmarket covered in this report is segmented –

1) By Product: Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Other Products

2) By Guidance Technique: Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques

3) By Application: Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications

4) By End-User: Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers

Subsegments:

1) By Needle-Based Biopsy Instruments: Core Needle Biopsy Devices, Fine Needle Aspiration (FNA) Devices, Vacuum-Assisted Biopsy Devices

2) By Procedure Trays: Pre-Packaged Biopsy Procedure Trays, Customizable Procedure Trays

3) By Localization Wires: Hook Wire Localization Devices, Radar Localization Devices, Magnetic Localization Devices

4) By Other Products: Biopsy Markers, Biopsy Imaging Systems, Biopsy Guidance Systems

What Long-Term Trends Will Shape The Future Growth Of The Smart Biopsy Devices Industry?

Leading corporations within the smart biopsy device sector are actively developing cutting-edge merchandise, exemplified by breast biopsy markers, aiming to elevate the accuracy and overall efficacy of identifying breast cancer. These particular markers serve the crucial function of precisely delineating where tissue was removed during the biopsy procedure, thereby assisting in the planning of subsequent therapies and confirming that the area of concern is appropriately followed for any possible malignant changes. As an illustration, in August of 2022, Mammotome, a firm based in the United States specializing in medical equipment, introduced the Mammotome DualCore Dual Stage Core Biopsy System, which represents a less invasive apparatus for breast biopsies employing a two-step mechanism to secure precise, superior quality tissue specimens. This system frequently sees application alongside ultrasound guidance to facilitate breast cancer diagnoses that are both accurate, secure, and time-efficient, and it possesses the capability to be integrated with sophisticated breast biopsy markers, thus affording healthcare providers a thorough and pioneering methodology for performing ultrasound-assisted breast biopsies.

Who Are The Major Companies Operating In The Smart Biopsy Devices Market?

Major companies operating in the smart biopsy devices market include Cardinal Health Inc, General Electric Company, Medtronic Plc, Danaher Corporation, Canon Medical Systems Corporation, Toshiba Corporation, Siemens Healthineers, FUJIFILM Holdings Corporation, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Hologic Inc., Cook Medical Inc., CONMED Corporation, Leica Biosystems, Argon Medical Devices Inc., Esaote SpA, SOMATEX Medical Technologies GmbH, Planmed Oy, TSK Laboratory Europe B.V., DTR Medical Ltd., INRAD Inc., Sterylab Srl, EndoMed Systems GmbH

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

Which Region Currently Holds The Largest Share Of The Smart Biopsy Devices Market?

North America was the largest region in the smart biopsy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Smart Biopsy Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12271&type=smp

Browse Through More Reports Similar to the Global Smart Biopsy Devices Market 2025, By The Business Research Company

Milking Machines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/milking-machines-global-market-report

Cheese Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cheese-global-market-report

Refrigerated Warehousing And Storage Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/refrigerated-warehousing-and-storage-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795